Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns

As of now, the COVID-19 pandemic has spread to over 770 million confirmed cases and caused approximately 7 million deaths. While several vaccines and monoclonal antibodies (mAb) have been developed and deployed, natural selection against immune recognition of viral antigens by antibodies has fueled...

Descripción completa

Detalles Bibliográficos
Autores principales: Abassi, Leila, Bertoglio, Federico, Mačak Šafranko, Željka, Schirrmann, Thomas, Greweling-Pils, Marina, Seifert, Oliver, Khan, Fawad, Katzmarzyk, Maeva, Jacobsen, Henning, Gödecke, Natascha, Heine, Philip Alexander, Frenzel, André, Nowack, Helena, Dübel, Stefan, Kurolt, Ivan-Christian, Kontermann, Roland E., Markotić, Alemka, Schubert, Maren, Hust, Michael, Čičin-Šain, Luka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675157/
https://www.ncbi.nlm.nih.gov/pubmed/38005829
http://dx.doi.org/10.3390/v15112153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675157/
https://www.ncbi.nlm.nih.gov/pubmed/38005829
http://dx.doi.org/10.3390/v15112153

Ejemplares similares